Get the latest news, insights, and market updates on AMPH (Amphastar Pharmaceuticals, Inc.). Explore the news page 3 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
AMPH Q3 Deep Dive: Pipeline Expansion and Core Product Growth Offset Margin Pressures
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported Q3 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $191.8 million. Its non-GAAP profit of $0.93 per share was 12.7% above analysts’ consensus estimates. Nov 10, 2025 - $AMPH
Why Are Amphastar Pharmaceuticals (AMPH) Shares Soaring Today
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 10.9% in the afternoon session after the stock's positive momentum continued as the company reported third-quarter financial results that surpassed analyst expectations. Amphastar posted revenue of $191.8 million and adjusted earnings of $0.93 per share, beating Wall Street's consensus estimates. The strong performance was reportedly driven by robust sales of its products Baqsimi and Primatene Mist. Following the resu Nov 10, 2025 - $AMPH
A Fresh Look at Amphastar Pharmaceuticals (AMPH) Valuation After Recent Share Price Decline
Amphastar Pharmaceuticals (AMPH) shares have experienced some movement over the past month, drawing attention from investors curious about what might be driving the stock’s direction recently. It is an interesting case as we look closer at its valuation. See our latest analysis for Amphastar Pharmaceuticals. Amphastar Pharmaceuticals’ share price has faced headwinds lately, sliding 33.9% year-to-date and turning in a total shareholder return of -50.3% over the past year. While recent declines... Nov 9, 2025 - $AMPH
Why Amphastar Pharmaceuticals (AMPH) Stock Is Up Today
Shares of pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) jumped 4.9% in the afternoon session after the company reported third-quarter 2025 financial results that surpassed analyst expectations. Nov 7, 2025 - $AMPH
Here's What Key Metrics Tell Us About Amphastar (AMPH) Q3 Earnings
The headline numbers for Amphastar (AMPH) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. Nov 6, 2025 - $AMPH
Amphastar: Q3 Earnings Snapshot
RANCHO CUCAMONGA, Calif. AP) — Amphastar Pharmaceuticals Inc. AMPH) on Thursday reported third-quarter earnings of $17.4 million. Nov 6, 2025 - $AMPH
Amphastar Pharmaceuticals (NASDAQ:AMPH) Delivers Strong Q3 Numbers
Pharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales were flat year on year at $191.8 million. Its non-GAAP profit of $0.93 per share was 12.7% above analysts’ consensus estimates. Nov 6, 2025 - $AMPH
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple